18 Year Old Young Teen

18 Year Old Young Teen

For a full list of topics: A-Z Index

Facebook
Twitter
LinkedIn
Syndicate

Finding and Updating Vaccine Records
The Vaccines for Children (VFC) Program

CDC INFORMATION

About CDC
Jobs
Funding
Policies
File Viewers & Players
Other Languages

CONNECT WITH CDC

Facebook
Twitter
Instagram
LinkedIn
Snapchat

Youtube
Syndicate
CDC TV
RSS
Email

Español
繁體中文
Tiếng Việt
한국어
Tagalog
Русский
العربية
Kreyòl Ayisyen
Français
Polski
Português
Italiano
Deutsch
日本語
فارسی
English

Facebook

Twitter

Instagram

LinkedIn

Snapchat

Youtube
Syndicate
CDC TV
RSS
Email

CDC Website Exit Disclaimer external icon

Exit Notification / Disclaimer Policy

Close

Links with this icon indicate that you are leaving the CDC website.

The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.

For more information on CDC's web notification policies, see Website Disclaimers .

CDC recommends COVID-19 vaccination for everyone 5 years of age and older to help protect against COVID-19.
After your child gets a vaccination, some people, including preteens, might experience the following:
Serious side effects are rare. To learn more about the possible side effects, read the Vaccine Information Sheet(s) .
If your child missed a vaccine, now is a good time for your child to catch up. Make an appointment for your child to get caught up if they haven’t received vaccines to protect against any of the following diseases:
Does your teen have an opportunity for travel outside the United States?
Plan four to six weeks before your trip. You may need this much time to complete a vaccine series, and your body needs time to build up immunity. Be sure to find out vaccine recommendations and requirements for your travel destination .
Before your child enters college, a technical school, or university, check that his or her vaccinations are up to date. These include childhood, preteen, and teen vaccinations. Many states recommend and several states require that some college students receive the meningococcal conjugate vaccine .
College campuses have reported outbreaks of serogroup B meningococcal disease during the last several years. Meningococcal conjugate vaccines do not include protection against serogroup B meningococcal disease. There are MenB vaccines that do provide protection against serogroup B meningococcal disease.

All Titles TV Episodes Celebs Companies Keywords Advanced Search
Fully supported English (United States) Partially supported Français (Canada) Français (France) Deutsch (Deutschland) हिंदी (भारत) Italiano (Italia) Português (Brasil) Español (España) Español (México)

Copy from this list

Export

Report this list

List your movie, TV & celebrity picks.

Views:
36,892
| in last week 280

See all lists by itsallgoodinthehood5 »

Kendall Nicole Jenner was born on November 3, 1995 in Los Angles, California, to parents Kris Jenner (née Kristen Mary Houghton) and Caitlyn Jenner (formerly known as Bruce Jenner), a U.S Olympic gold medal decathlon winner. Kendall is an American socialite, television personality and model. She is...

Maddie Hasson is known for leading YouTube Premium's original series "Impulse," starring as 'Henrietta (Henry) Coles.' Based on the third novel in the "Jumper" book series written by Steven Gould, "Impulse" follows small-town teenager Henry (Hasson) as she discovers her extraordinary ability to ...

Victory Van Tuyl was born on September 16, 1995 in Atlanta, Georgia, USA. She is an actress, known for Bedeviled (2016), Castle (2009) and Marvin Marvin (2012).

Georgina Helen Henley was born July 9, 1995 in Ilkley, Bradford, West Yorkshire, England, the youngest of three daughters of Mike and Helen Henley. When she was young, she joined a local drama group called "Upstagers". It was there that she started her acting career, participating in stage ...

Sammi Hanratty has been acting for more than half her life. She's had the pleasure of working with some of Hollywood's biggest names including Academy Award winning director Robert Zemeckis, Simon West, Barry Sonnenfeld, Jim Carrey, Robin Wright, Gary Oldman, Cary Elwes, Ray Liotta, Cuba Gooding Jr...

Liana Liberato is an actress born in Galveston, Texas. She's been working professionally since she was 9 years old. Most notably known for her roles in Trust, Best of Me, If I Stay, and To the Bone. At 14 she won the Silver Hugo Award Best Actress at the Chicago International Film Festival for her ...

Rosie Day was born in Cambridge. Her first film was playing Angel in Paul Hyett's feature film The Seasoning House for which she received positive acclaim and won four Best Actress awards. Acting since a young age she has starred in many TV shows and dramas such as ITV's Homefront, Harley Street, ...

Quinn Shephard is a writer, director and actress based out of the New York area, with a career spanning two decades. At age 15, Shephard began writing her debut feature Blame Blame (2017), inspired by playing Abigail Williams in a New Jersey regional production of Arthur Miller's The Crucible. She ...

Claire Julien was born on January 11, 1995 in Los Angeles, California, USA. She is an actress, known for The Bling Ring (2013), The Dark Knight Rises (2012) and Phoenix: Chloroform (2013).

Lulu Antariksa was born in Southern California, a first-generation American of Indonesian and German/Dutch descent and the youngest of four children. Her desire for storytelling started at the age of four and only grew over time, finding itself in multiple different mediums. She got her start in ...

Boards are the best place to save images and video clips. Collect, curate and comment on your files.
Unable to complete your request at present. Please try again later or contact us if the issue continues.
Experience our new, interactive way to find visual insights that matter.
Images Creative Editorial Video Creative Editorial
Best match Newest Oldest Most popular
Any date Last 24 hours Last 48 hours Last 72 hours Last 7 days Last 30 days Last 12 months Custom date range
Release not important Released/No release required
Online only Offline only Online and offline
1,800 Beautiful 18 Year Old Girls Premium Video Footage
© 2022 Getty Images. The Getty Images design is a trademark of Getty Images.
Access the best of Getty Images and iStock with our simple subscription plan . Millions of high-quality images, video, and music options await you.
Tap into Getty Images’ global-scale, data-driven insights and network of over 340,000 creators to create content exclusively for your brand .
Streamline your workflow with our best-in-class digital asset management system . Organise, control, distribute, and measure all of your digital content.
Grow your brand authentically by sharing brand content with the internet’s creators.

For a full list of topics: A-Z Index

Facebook
Twitter
LinkedIn
Syndicate

Age 9–16 years living in dengue endemic areas AND have laboratory confirmation of previous dengue infection

3-dose series administered at 0, 6, and 12 months

Endemic areas include Puerto Rico, American Samoa, US Virgin Islands, Federated States of Micronesia, Republic of Marshall Islands, and the Republic of Palau. For updated guidance on dengue endemic areas and pre-vaccination laboratory testing see https://www.cdc.gov/mmwr/volumes/70/rr/rr7006a1.htm and https://www.cdc.gov/dengue/vaccine/hcp/index.html .

5-dose series at age 2, 4, 6, 15–18 months, 4–6 years

Prospectively: Dose 4 may be administered as early as age 12 months if at least 6 months have elapsed since dose 3.
Retrospectively: A 4th dose that was inadvertently administered as early as age 12 months may be counted if at least 4 months have elapsed since dose 3.

Dose 5 is not necessary if dose 4 was administered at age 4 years or older and at least 6 months after dose 3.
For other catch-up guidance, see Table 2 .

ActHIB ® , Hiberix ® , Pentacel ® , or Vaxelis ® : 4-dose series (3 dose primary series at age 2, 4, and 6 months, followed by a booster dose* at age 12–15 months)

*Vaxelis ® is not recommended for use as a booster dose. A different Hib-containing vaccine should be used for the booster dose.

PedvaxHIB ® : 3-dose series (2-dose primary series at age 2 and 4 months, followed by a booster dose at age 12–15 months)

Unvaccinated* persons age 5 years or older
Unvaccinated* persons age 15 months or older
Unvaccinated* persons age 5–18 years

2-dose series (minimum interval: 6 months) at age 12–23 months

Unvaccinated persons through age 18 years should complete a 2-dose series (minimum interval: 6 months).
Persons who previously received 1 dose at age 12 months or older should receive dose 2 at least 6 months after dose 1.
Adolescents age 18 years or older may receive the combined HepA and HepB vaccine, Twinrix ® , as a 3-dose series (0, 1, and 6 months) or 4-dose series (3 doses at 0, 7, and 21–30 days, followed by a booster dose at 12 months).

Birth dose (monovalent HepB vaccine only)

Mother is HBsAg-negative:

All medically stable infants ≥2,000 grams: 1 dose within 24 hours of birth
Infants <2,000 grams: Administer 1 dose at chronological age 1 month or hospital discharge (whichever is earlier and even if weight is still <2,000 grams).

Mother is HBsAg-positive:

Administer HepB vaccine and hepatitis B immune globulin (HBIG) (in separate limbs) within 12 hours of birth, regardless of birth weight. For infants <2,000 grams, administer 3 additional doses of vaccine (total of 4 doses) beginning at age 1 month.
Test for HBsAg and anti-HBs at age 9–12 months. If HepB series is delayed, test 1–2 months after final dose.

Mother's HBsAg status is unknown:

Administer HepB vaccine within 12 hours of birth, regardless of birth weight.
For infants <2,000 grams, administer HBIG in addition to HepB vaccine (in separate limbs) within 12 hours of birth. Administer 3 additional doses of vaccine (total of 4 doses) beginning at age 1 month.
Determine mother’s HBsAg status as soon as possible. If mother is HBsAg-positive, administer HBIG to infants ≥2,000 grams as soon as possible, but no later than 7 days of age.

3-dose series at age 0, 1–2, 6–18 months (use monovalent HepB vaccine for doses administered before age 6 weeks)
Infants who did not receive a birth dose should begin the series as soon as feasible (see Table 2 ).
Administration of 4 doses is permitted when a combination vaccine containing HepB is used after the birth dose.
Minimum age for the final (3rd or 4th ) dose: 24 weeks
Minimum intervals: dose 1 to dose 2: 4 weeks / dose 2 to dose 3: 8 weeks / dose 1 to dose 3: 16 weeks (when 4 doses are administered, substitute “dose 4” for “dose 3” in these calculations)

Unvaccinated persons should complete a 3-dose series at 0, 1–2, 6 months.
Adolescents age 11–15 years may use an alternative 2-dose schedule with at least 4 months between doses (adult formulation Recombivax HB ® only).
Adolescents age 18 years or older may receive a 2-dose series of HepB (Heplisav-B ® ) at least 4 weeks apart.
Adolescents age 18 years or older may receive the combined HepA and HepB vaccine, Twinrix ® , as a 3-dose series (0, 1, and 6 months) or 4-dose series (3 doses at 0, 7, and 21–30 days, followed by a booster dose at 12 months).
For other catch-up guidance, see Table 2 .

HPV vaccination routinely recommended at age 11–12 years (can start at age 9 years) and catch-up HPV vaccination recommended for all persons through age 18 years if not adequately vaccinated
2- or 3-dose series depending on age at initial vaccination:

Age 9 –14 years at initial vaccination : 2-dose series at 0, 6–12 months (minimum interval: 5 months; repeat dose if administered too soon)
Age 15 years or older at initial vaccination: 3-dose series at 0, 1–2 months, 6 months (minimum intervals: dose 1 to dose 2: 4 weeks / dose 2 to dose 3: 12 weeks / dose 1 to dose 3: 5 months; repeat dose if administered too soon)

Interrupted schedules: If vaccination schedule is interrupted, the series does not need to be restarted.
No additional dose recommended when any HPV vaccine series has been completed using the recommended dosing intervals.

Immunocompromising conditions, including HIV infection: 3-dose series, even for those who initiate vaccination at age 9 through 14 years.
History of sexual abuse or assault: Start at age 9 years.
Pregnancy: Pregnancy testing not needed before vaccination; HPV vaccination not recommended until after pregnancy; no intervention needed if vaccinated while pregnant

Use any influenza vaccine appropriate for age and health status annually:

2 doses, separated by at least 4 weeks, for children age 6 months–8 years who have received fewer than 2 influenza vaccine doses before July 1, 2021, or whose influenza vaccination history is unknown (administer dose 2 even if the child turns 9 between receipt of dose 1 and dose 2)
1 dose for children age 6 months–8 years who have received at least 2 influenza vaccine doses before July 1, 2021
1 dose for all persons age 9 years or older

For the 2021-2022 season, see www.cdc.gov/mmwr/volumes/70/rr/rr7005a1.htm .
For the 2022–23 season, see the 2022–23 ACIP influenza vaccine recommendations.

Unvaccinated children and adolescents: 2-dose series at least 4 weeks apart
The maximum age for use of MMRV is 12 years.
Minimum interval between MMRV doses: 3 months

2-dose series at age 11–12 years, 16 years

Age 13–15 years: 1 dose now and booster at age 16–18 years (minimum interval: 8 weeks)
Age 16–18 years: 1 dose

Adolescents not at increased risk age 16–23 years (preferred age 16–18 years) based on shared clinical decision-making:

Bexsero ® : 2-dose series at least 1 month apart
Trumenba ® : 2-dose series at least 6 months apart; if dose 2 is administered earlier than 6 months, administer a 3 rd dose at least 4 months after dose 2.

4-dose series at age 2, 4, 6, 12–15 months

4-dose series at ages 2, 4, 6–18 months, 4–6 years; administer the final dose on or after age 4 years and at least 6 months after the previous dose.
4 or more doses of IPV can be administered before age 4 years when a combination vaccine containing IPV is used. However, a dose is still recommended on or after age 4 years and at least 6 months after the previous dose.

Rotarix ® : 2-dose series at age 2 and 4 months
RotaTeq ® : 3-dose series at age 2, 4, and 6 months
If any dose in the series is either RotaTeq ® or unknown, default to 3-dose series.

Do not start the series on or after age 15 weeks, 0 days.
The maximum age for the final dose is 8 months, 0 days.
For other catch-up guidance, see Table 2 .

Adolescents age 11–12 years: 1 dose Tdap
Pregnancy: 1 dose Tdap during each pregnancy, preferably in early part of gestational weeks 27–36.
Tdap may be administered regardless of the interval since the last tetanus- and diphtheria-toxoid-containing vaccine.

Wound management in persons age 7 years or older with history of 3 or more doses of tetanus-toxoid-containing vaccine: For clean and minor wounds, administer Tdap or Td if more than 10 years since last dose of tetanus-toxoid-containing vaccine; for all other wounds, administer Tdap or Td if more than 5 years since last dose of tetanus-toxoid-containing vaccine. Tdap is preferred for persons age 11 years or older who have not previously received Tdap or whose Tdap history is unknown. If a tetanus-toxoid-containing vaccine is indicated for a pregnant adolescent, use Tdap.
For detailed information, see www.cdc.gov/mmwr/volumes/69/wr/mm6903a5.htm .

Ensure persons age 7–18 years without evidence of immunity (see MMWR at www.cdc.gov/mmwr/pdf/rr/rr5604.pdf pdf icon ) have a 2-dose series:

Age 7–12 years: routine interval: 3 months (a dose inadvertently administered after at least 4 weeks may be counted as valid)
Age 13 years and older : routine interval: 4–8 weeks (minimum interval: 4 weeks)
The maximum age for use of MMRV is 12 years.

Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component 3
Severe immunodeficiency (e.g., hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, long- term immunosuppressive therapy or patients with HIV infection who are severely immunocompromised)

Pregnancy
HIV infection without evidence of severe immunosuppression
Moderate or severe acute illness with or without fever

Diphtheria, tetanus, pertussis (DTaP)

Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component 3
For DTaP only: Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTP or DTaP

Guillain-Barré syndrome (GBS) within 6 weeks after previous dose of tetanus-toxoid–containing vaccine
History of Arthus-type hypersensitivity reactions after a previous dose of diphtheria-toxoid— containing or tetanus-toxoid– containing vaccine; defer vaccination until at least 10 years have elapsed since the last tetanus-toxoid- containing vaccine
For DTaP only: Progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, progressive encephalopathy; defer DTaP until neurologic status clarified and stabilized
Moderate or severe acute illness with or without fever

Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component 3
For Hiberix, ActHib, and PedvaxHIB only: History of severe allergic reaction to dry natural latex
Age <6 weeks

Moderate or severe acute illness with or without fever

Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component 3 including neomycin

Moderate or severe acute illness with or without fever

Severe allergic r
Threesome Teen Full
Spycam Com
Madison Ivy Threesome

18 Year Old Young Teen

Report Page